Tenemos algunos problemas en este momento. Los datos de mercado de esta página no están disponibles actualmente. Te pedimos un poco de paciencia, mientras tratamos de resolver el problema y restauramos tus listas personalizadas.

U.S. markets open in 2 hours 3 minutes
  • Motley Fool

    Here's Why Shares in FedEx Surged Higher This Week

    Cost-cutting measures and improving end markets gave investors cause for optimism this week.

  • Reuters

    Indian rupee sees mild gains, bonds muted as JPM index flows undershoot estimates

    India's rupee rose slightly, while government bonds were unable to gain meaningfully on the day of the much-awaited inclusion of the country's sovereign debt into a widely-tracked JPMorgan debt index as inflows underwhelmed investors. Foreign exchange market indicators had pointed to inflows, likely due to passive funds buying bonds, but multiple market participants said the quantum of inflows was sharply lower than anticipated. By 4:00 p.m. IST on Friday, traders said a maximum of 40 billion rupees ($480 million) may have come into government bonds.

  • Business Wire

    Net Asset Value(s)

    LONDON, June 28, 2024-- FundsDate

  • Reuters

    Russia's VTB bank says US sanctions have complicated cross-border transactions

    U.S. sanctions imposed on Moscow this month have complicated the foreign trade operations of Russian banks, but they are gradually adapting to the new realities, the finance director of VTB, Russia's second-largest lender, said on Friday. On June 12, the U.S. imposed Ukraine-related sanctions on the Moscow Exchange, which stopped trading in currency pairs with the dollar and euro. The sanctions package also targeted China-based companies selling semiconductors to Moscow, and the U.S. Treasury said it was raising "the risk of secondary sanctions for foreign financial institutions that deal with Russia's war economy," effectively threatening them with losing access to the U.S. financial system.

  • GlobeNewswire

    CHMP adopts positive opinion for BALVERSA® (erdafitinib) for the treatment of adult patients with unresectable or metastatic urothelial carcinoma with susceptible FGFR3 genetic alterations

    Pending approval, erdafitinib would become the first therapy targeting FGFR3 alterations in patients with metastatic urothelial carcinoma, one of Europe’s most common cancers1 The CHMP’s recommendation is based on results from Cohort 1 of the Phase 3 THOR study, which showed a 36 percent reduction in the risk of death with erdafitinib versus chemotherapy2 BEERSE, Belgium , June 28, 2024 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Comm

  • Just Food

    First death linked to UK E. coli outbreak

    As of 25 June, there have been a total of 275 confirmed cases in the UK, with case reporting rates “declining”, the UKHSA said.

  • Engadget

    The Morning After: What to expect at Samsung’s Unpacked 2024 event

    The biggest news stories this morning: Please don’t get your news from AI chatbots, Bluesky starter packs help new users find their way, Amazon is giving away 15 free video games ahead of Prime Day 2024.

  • PR Newswire

    Ecuador and Paraguay governments join BEB leaders to plan future of child welfare systems

    BEB hosted the first-ever multi-country delegation with Ecuador and Paraguay government officials in Plano, TX. The two countries are leaders in using Children First Software (CFS) to advance child welfare systems and came together to discuss lessons learned and plans for the future.

  • GlobeNewswire

    Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)

    Positive recommendation is based on two Phase III studies. In addition to robust retinal drying with Vabysmo, these data show early and sustained vision improvements, which are non-inferior to aflibercept If approved, Vabysmo would be the first and only bispecific antibody treatment available for the nearly one million people with RVO in the European UnionVabysmo is already approved in the US and Japan for RVO and in more than 95 countries around the world for people living with nAMD and DME Bas

  • Business Wire

    Citi Securities Services Wins ETF Mandate from Asset Manager Nuveen

    NEW YORK, June 28, 2024--Winning a new mandate from asset manager Nuveen, Citi Securities Services’ ETF Services business has onboarded 23 new ETFs with approximately US$9 billion in assets in North America. The book is comprised of both transparent and non-transparent ETFs.